Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Abstract | Full HTML Article | PDF ecancer 13 913 / https://doi.org/10.3332/ecancer.2019.913

Special Issue

How do clinicians rate patient’s performance status using the ECOG performance scale? A mixed-methods exploration of variability in decision-making in oncology

Background: Medical decisions made by oncology clinicians have serious implications, even when made collaboratively with the patient. Clinicians often use the Eastern Clinical Oncology Group (ECOG) performance status (PS) scores to help them make treatment-related decisions.

Methods: The current study explores the variability of the ECOG score when applied to 12 predetermined specially designed clinical case vignettes presented to a group of oncology clinicians (n = 72). The quantitative analysis included evaluation of variability of ECOG PS scores and exploration of rater and patient-related factors which may influence the final ECOG rating. In-depth interviews were conducted with oncology clinicians to ascertain factors that they felt were important while making treatment-related decisions. Basic and global themes were generated following qualitative data analysis.

Results: Quantitative results showed that there was poor agreement in ECOG rating between raters. Overall concordance with the gold standard rating ranged between 19.4% and 56.9% for the vignettes. Moreover, patients deemed to have socially desirable qualities (p < 0.004) were rated to have better PS and women patients (p < 0.004) to have worse PS. Clinicians having international work experience had increased concordance with ECOG PS rating. Qualitative results showed that ‘perceived socio-economic background of the patient’, ‘age of the patient’, ‘patient’s and family’s preferences’ and ‘past treatment response’ were the major themes highlighted by respondents that influenced the treatment-related decisions made by clinicians.

Conclusion: There is considerable variability in ECOG PS determined by clinicians. Decision-making in oncology is complex, multifactorial and is influenced by rater and patient-related factors.

Keywords: decision making, ECOG, oncology, heuristics

Loading Article Metrics ... Please wait

Author interviews

Soumitra Datta

Tata Medical Centre, Kolkata, India and EGA UCL Institute for Women’s Health, University College London, UK

Related articles

Special Issue: Building a comprehensive cancer survivorship program

Abstract | Full Article | PDF Published: 12 Dec 2019 / https://doi.org/10.3332/ecancer.2019.992

Special Issue: Evaluation of a charity-led secondary breast cancer support day: a model of survivorship care

Abstract | Full Article | PDF Published: 12 Dec 2019 / https://doi.org/10.3332/ecancer.2019.991

Special Issue: Recruiting cancer survivors into research studies using online methods: a secondary analysis from an international cancer survivorship cohort study

Abstract | Full Article | PDF Published: 12 Dec 2019 / https://doi.org/10.3332/ecancer.2019.990

Special Issue: The experiences of giving and receiving social support for men with localised prostate cancer and their partners

Abstract | Full Article | PDF Published: 12 Dec 2019 / https://doi.org/10.3332/ecancer.2019.989

Special Issue: A systematic review of laser therapy for vulvovaginal atrophy/genitourinary syndrome of menopause in breast cancer survivors

Abstract | Full Article | PDF Published: 12 Dec 2019 / https://doi.org/10.3332/ecancer.2019.988

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation